Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Validation of the Neurological Fatigue Index for Stroke (NFI-Stroke).
Efficacy of rituximab in refractory neuromyelitis optica.
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.
Causes of death among persons with multiple sclerosis.
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis.
Estrogen regulates excitatory amino acid carrier 1 (EAAC1) expression through sphingosine kinase 1 (SphK1) transacting FGFR-mediated ERK signaling in rat C6 astroglial cells.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
Evaluation of the impact of neutralizing antibodies on IFNβ response.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Newer therapies for multiple sclerosis.
Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders?
Next-Generation Sequencing Identifies MicroRNAs that Associate with Pathogenic Autoimmune Neuroinflammation in Rats.

Pages